Table 1.

Univariate and Multivariate analyses for recurrence-free survival

Risk factors	Univariate analysis			Multivariate analysis
	HR	P value	95% CI	HR	P value	95% CI
MEG3 expression	0.111	0.002	0.027 ∼ 0.451	0.159	0.040	0.028 ∼ 0.919
FIGO stage, (I, II)	3.687	<0.001	1.780 ∼ 7.634	3.033	0.005	1.400 ∼ 6.571
Lymph nodes metastasis (Negative, Positive)	2.095	0.043	1.023 ∼ 4.291	2.259	0.048	1.007 ∼ 5.070
Differentiation (Well/Moderately, Poorly)	2.134	0.040	1.036 ∼ 4.396	0.670	0.406	0.201 ∼ 1.722
Depth of invasion (≤2/3, >2/3)	1.358	0.403	0.663 ∼ 2.783
HR HPV infection (Negative, Positive)	1.501	0.347	0.643 ∼ 3.502
Tumor size	1.243	0.132	0.936 ∼ 1.652
LVSI (Negative, Positive)	0.797	0.538	0.387 ∼ 1.643
Age	0.998	0.894	0.967 ∼ 1.030
Histology (Squamous, Adenocarcinoma)	0.927	0.961	0.412 ∼ 2.240
Menopause (Yes, No)	1.426	0.333	0.696 ∼ 2.921

HR hazard ratio